630 related articles for article (PubMed ID: 17176300)
1. Validation of a melasma quality of life questionnaire for Brazilian Portuguese language: the MelasQoL-BP study and improvement of QoL of melasma patients after triple combination therapy.
Cestari TF; Hexsel D; Viegas ML; Azulay L; Hassun K; Almeida AR; Rêgo VR; Mendes AM; Filho JW; Junqueira H
Br J Dermatol; 2006 Dec; 156 Suppl 1():13-20. PubMed ID: 17176300
[TBL] [Abstract][Full Text] [Related]
2. Validation of a melasma quality of life questionnaire for the Turkish language: the MelasQoL-TR study.
Dogramaci AC; Havlucu DY; Inandi T; Balkrishnan R
J Dermatolog Treat; 2009; 20(2):95-9. PubMed ID: 18720186
[TBL] [Abstract][Full Text] [Related]
3. Effect of melasma on quality of life in a sample of women living in southern Brazil.
Freitag FM; Cestari TF; Leopoldo LR; Paludo P; Boza JC
J Eur Acad Dermatol Venereol; 2008 Jun; 22(6):655-62. PubMed ID: 18410339
[TBL] [Abstract][Full Text] [Related]
4. Melasma in Latina patients: cross-cultural adaptation and validation of a quality-of-life questionnaire in Spanish language.
Dominguez AR; Balkrishnan R; Ellzey AR; Pandya AG
J Am Acad Dermatol; 2006 Jul; 55(1):59-66. PubMed ID: 16781293
[TBL] [Abstract][Full Text] [Related]
5. Psychometrican analysis and dimensional structure of the Brazilian version of melasma quality of life scale (MELASQoL-BP).
Maranzatto CF; Miot HA; Miot LD; Meneguin S
An Bras Dermatol; 2016; 91(4):422-8. PubMed ID: 27579735
[TBL] [Abstract][Full Text] [Related]
6. Preventing melasma recurrence: prescribing a maintenance regimen with an effective triple combination cream based on long-standing clinical severity.
Arellano I; Cestari T; Ocampo-Candiani J; Azulay-Abulafia L; Bezerra Trindade Neto P; Hexsel D; Machado-Pinto J; Muñoz H; Rivitti-Machado MC; Sittart JA; Trindade de Almeida AR; Rego V; Paliargues F; Marques-Hassun K
J Eur Acad Dermatol Venereol; 2012 May; 26(5):611-8. PubMed ID: 21623930
[TBL] [Abstract][Full Text] [Related]
7. Development and validation of a health-related quality of life instrument for women with melasma.
Balkrishnan R; McMichael AJ; Camacho FT; Saltzberg F; Housman TS; Grummer S; Feldman SR; Chren MM
Br J Dermatol; 2003 Sep; 149(3):572-7. PubMed ID: 14510991
[TBL] [Abstract][Full Text] [Related]
8. Development and validation of a Hindi language health-related quality of life questionnaire for melasma in Indian patients.
Sarkar R; Garg S; Dominguez A; Balkrishnan R; Jain RK; Pandya AG
Indian J Dermatol Venereol Leprol; 2016; 82(1):16-22. PubMed ID: 26728805
[TBL] [Abstract][Full Text] [Related]
9. Melasma and assessment of the quality of life in Brazilian women.
Ikino JK; Nunes DH; Silva VP; Fröde TS; Sens MM
An Bras Dermatol; 2015; 90(2):196-200. PubMed ID: 25830989
[TBL] [Abstract][Full Text] [Related]
10. Treating epidermal melasma with a 4% hydroquinone skin care system plus tretinoin cream 0.025%.
Grimes P; Watson J
Cutis; 2013 Jan; 91(1):47-54. PubMed ID: 23461059
[TBL] [Abstract][Full Text] [Related]
11. Evaluating the quality of life among melasma patients using the MELASQoL scale: A systematic review and meta-analysis.
Zhu Y; Zeng X; Ying J; Cai Y; Qiu Y; Xiang W
PLoS One; 2022; 17(1):e0262833. PubMed ID: 35085327
[TBL] [Abstract][Full Text] [Related]
12. Comparison of a skin-lightening cream targeting melanogenesis on multiple levels to triple combination cream for melasma.
Monheit GD; Dreher F
J Drugs Dermatol; 2013 Mar; 12(3):270-4. PubMed ID: 23545908
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of a new triple-combination agent for the treatment of facial melasma.
Taylor SC; Torok H; Jones T; Lowe N; Rich P; Tschen E; Menter A; Baumann L; Wieder JJ; Jarratt MM; Pariser D; Martin D; Weiss J; Shavin J; Ramirez N
Cutis; 2003 Jul; 72(1):67-72. PubMed ID: 12889718
[TBL] [Abstract][Full Text] [Related]
14. Improved quality of life with effective treatment of facial melasma: the pigment trial.
Balkrishnan R; Kelly AP; McMichael A; Torok H
J Drugs Dermatol; 2004; 3(4):377-81. PubMed ID: 15303781
[TBL] [Abstract][Full Text] [Related]
15. Oral Tranexemic Acid With Triple Combination Cream (Flucinolone+Hydroquinone+Tretinoin) Versus Triple Combination Cream Alone In Treatment Of Melasma.
Basit A; Rahman A; Uddin R
J Ayub Med Coll Abbottabad; 2021; 33(2):293-298. PubMed ID: 34137548
[TBL] [Abstract][Full Text] [Related]
16. Melasma in Latin America: options for therapy and treatment algorithm.
Cestari T; Arellano I; Hexsel D; Ortonne JP;
J Eur Acad Dermatol Venereol; 2009 Jul; 23(7):760-72. PubMed ID: 19646135
[TBL] [Abstract][Full Text] [Related]
17. Development and validation of a multidimensional questionnaire for evaluating quality of life in melasma (HRQ-melasma).
Pollo CF; Miot LDB; Meneguin S; Miot HA
An Bras Dermatol; 2018 Jun; 93(3):391-396. PubMed ID: 29924234
[TBL] [Abstract][Full Text] [Related]
18. Combination of glycolic acid peel and topical 20% azelaic acid cream in melasma patients: efficacy and improvement in quality of life.
Dayal S; Sahu P; Dua R
J Cosmet Dermatol; 2017 Mar; 16(1):35-42. PubMed ID: 27500896
[TBL] [Abstract][Full Text] [Related]
19. Role of broad-spectrum sunscreen alone in the improvement of melasma area severity index (MASI) and Melasma Quality of Life Index in melasma.
Sarkar R; Ghunawat S; Narang I; Verma S; Garg VK; Dua R
J Cosmet Dermatol; 2019 Aug; 18(4):1066-1073. PubMed ID: 31033184
[TBL] [Abstract][Full Text] [Related]
20. Hydroquinone 4%, tretinoin 0.05%, fluocinolone acetonide 0.01%: a safe and efficacious 12-month treatment for melasma.
Torok HM; Jones T; Rich P; Smith S; Tschen E
Cutis; 2005 Jan; 75(1):57-62. PubMed ID: 15732437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
